Inovio Pharma (INO) Tops Q3 EPS by 4c
Tweet
Share
E-mailGet Alerts INO Hot Sheet
Price: $1.23 +1.65%
EPS Growth %: +75.9%
Financial Fact:
Total revenue: 12.54M
Today's EPS Names:
VIVO, OCCI, ALZN, More
EPS Growth %: +75.9%
Financial Fact:
Total revenue: 12.54M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Inovio Pharma (NASDAQ: INO) reported Q3 EPS of ($0.09), $0.04 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $390 thousand versus the consensus estimate of $116.67 thousand.
For earnings history and earnings-related data on Inovio Pharma (INO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Can global equities keep rising? UBS sees these factors driving upside
- Premarket movers: Xenon sinks on trial pause, Netflix hit by downgrade
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
